| Financial Year |
September 30 2020 |
| Monetary Funds |
66,645,085.54 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
88,522,135.65 |
| Advances to Suppliers |
14,367,984.25 |
| Other Receivables |
2,230,427.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
302,590,458.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,660,698.16 |
| Total Current Assets |
490,327,921.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
23,981,143.36 |
| Investment Properties |
-- |
| Fixed Assetes |
697,066,302.02 |
| Under-construction Projects |
114,830,897.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
61,930,438.97 |
| R&D expenses |
2,437,514.96 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
10,739,014.42 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
912,785,311.10 |
| Total Assets |
1,403,113,232.85 |
| Short-Term Loans |
71,897,416.53 |
| Trading Financial liabilities |
-- |
| Notes Payable |
30,000,000.00 |
| Accounts Payable |
133,653,478.94 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,413,947.89 |
| Taxes Payable |
6,094,134.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,841,645.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
24,810,912.15 |
| Other Current Liabilities |
57,256,239.92 |
| Sub-Total of Current Liabilities |
332,567,738.91 |
| Long-term Loans |
17,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
10,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
78,544,707.31 |
| Total Liabilities |
411,112,446.22 |
| Paid-In Capital(Or Share Stock) |
521,810,108.00 |
| Capital Surplus |
316,099,502.08 |
| Surplus Reserve |
31,601,274.21 |
| LESS:Treasury Stock |
2,536,560.00 |
| Undistributed Profits |
117,222,257.65 |
| Minority Stockholder's Interest |
7,804,204.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
984,196,581.94 |
| Owner's Equity（Stockholder's Equity） |
992,000,786.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,403,113,232.85 |
